XT
ACHV icon

XTX Topco’s Achieve Life Sciences ACHV Stock Holding History

XTX Topco’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$588K Buy
90,030
+71,812
+394% +$342K 0.01% 2301
2026
Q1 		$53.6K Sell
18,218
-874
-5% -$3.88K ﹤0.01% 3297
2025
Q4 		$94.9K Sell
19,092
-66,763
-78% -$291K ﹤0.01% 2648
2025
Q3 		$270K Buy
+85,855
New +$236K 0.01% 1588
2025
Q2 		– Sell
-37,021
Closed -$98.8K – 2282
2025
Q1 		$98.8K Buy
+37,021
New +$115K 0.01% 1872
2023
Q3 		– Sell
-14,841
Closed -$77K – 1512
2023
Q2 		$77K Buy
+14,841
New +$104K 0.01% 1193

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

XTX Topco's ACHV Position: Q2 2026 in Review

XTX Topco increased its Achieve Life Sciences (ACHV) stake by 394% in Q2 2026, buying an estimated $342K and bringing the position to 90,030 shares worth $588K. The position accounts for 0.01% of the portfolio, ranked #2301.

XTX Topco first reported a position in ACHV in Q2 2023 and has held it in 6 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • XTX Topco held 90,030 shares of Achieve Life Sciences worth $588K as of Q2 2026.
  • XTX Topco bought 71,812 Achieve Life Sciences shares in Q2 2026, an estimated $342K.
  • Achieve Life Sciences made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2301 holding.
  • XTX Topco first reported a position in Achieve Life Sciences in Q2 2023 and has held it in 6 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.